Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Apr 15:38:14654.
doi: 10.3389/ti.2025.14654. eCollection 2025.

Transplant Trial Watch

Simon R Knight  1   2 , John Fallon  1
Affiliations
Editorial

Transplant Trial Watch

Simon R Knight et al. Transpl Int. .
No abstract available

Keywords: antibody mediated rejection; immunosupression; kidney transplantation; liver transplantation; randomised controlled trial.

PubMed Disclaimer

Conflict of interest statement

SK has undertaken previous paid consultancy work for OrganOx Ltd. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Willicombe M, Roufosse C, Brookes P, Galliford JW, McLean AG, Dorling A, et al. Antibody-Mediated Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, And Predictors Of Poor Outcomeejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome. Transplantation (2011) 92:176-182. 10.1097/TP.0b013e318222c9c6 - DOI - PubMed
    1. van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D, et al. The Clinical Utility of Post-Transplant Monitoring of Donor-The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practicepecific Antibodies in Stable Renal Transplant Recipients: A Consensus Report with Guideline Statements for Clinical Practice. Transpl Int (2023) 36:11321. 10.3389/ti.2023.11321 - DOI - PMC - PubMed
    1. Knight SR, Thorne A, Lo Faro ML. Donor-Specific Cell-Free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review. Transplantation (2019) 103:273–83. 10.1097/TP.0000000000002482 - DOI - PubMed
    1. Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, et al. Donor-Derived Cell-Free DNA Monitoring for Early Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation: A Randomized Trial. Nephrology, Dialysis. Transplantation. Official Publication of the European Dialysis and Transplant Association - European Renal Association 2024; : gfae282. - PubMed

Publication types

LinkOut - more resources